|
|
- The group usually releases upbeat results with huge surprise rates.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
|
| Sector Generic Pharmaceuticals |
|
| | 1st jan. | Capitalisation (M$) | Investor Rating |
 |
 | MPH HEALTH CARE AG | -2.63% | 115 | - |
| |
|
|
|
| Sales 2020 |
17,5 M
21,2 M
21,2 M
|
| Net income 2020 |
-22,0 M
-26,7 M
-26,7 M
|
| Net Debt 2020 |
-
-
-
|
| P/E ratio 2020 |
-4,35x |
| Yield 2020 |
9,01% |
|
| Capitalization |
95,0 M
115 M
115 M
|
| Capi. / Sales 2020 |
5,43x |
| Capi. / Sales 2021 |
2,52x |
| Nbr of Employees |
424 |
| Free-Float |
100% |
|
Notations Surperformance© Fundamental ratings
|
Overall rating |
| Trading Rating |
- |
| Investor Rating |
- |
| Growth (Revenue) |
- |
| Valuation |
- |
| Finances |
- |
| Profitability |
- |
| Earnings quality |
|
| Business Predictability |
- |
| P/E ratio |
- |
| Potential |
|
| Yield |
- |
| Consensus |
- |
| 7 days EPS revision |
- |
| 4 months EPS revision |
- |
| 1 year EPS revision |
- |
| 4 months Revenue revision |
- |
| 1 year Revenue revision |
- |
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
